Virpax Pharmaceuticals, Inc.
VRPXDelisted Jul 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708331
Virpax Pharmaceuticals, Inc. was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Jul 10, 2024; 7 institutions reported holding it in 13F filings for Q1 2025, worth $34.9K in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Virpax Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 6 | 8 | +2 |
| Shares | 1.98K | 24.3K | +22.3K (+1,126.2%) |
| Value | $6.44K | $12.6K | +$6.14K (+95.4%) |
New holders (3)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Warberg Asset Management LLC | 20,000 | $10.3K | 0.00% |
| UBS Group AG | 1,087 | $562 | 0.00% |
| Bank of America Corp | 7 | $4 | 0.00% |
Sold out (1)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Wells Fargo & Company | 8 | $34 |